Adipocyte-specific deficiency of de novo sphingolipid biosynthesis leads to lipodystrophy and insulin resistance

Su Yeon Lee, Hui Young Lee, Jae Hwi Song, Goon Tae Kim, Suwon Jeon, Yoo Jeong Song, Jae Sung Lee, Jang Ho Hur, Hyun Hee Oh, Shi Young Park, Soon Mi Shim, Hyun Joo Yoo, Byung Cheon Lee, Xian Cheng Jiang, Cheol Soo Choi, Tae Sik Park

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Sphingolipids have been implicated in the etiology of chronic metabolic diseases. Here, we investigated whether sphingolipid biosynthesis is associated with the development of adipose tissues and metabolic diseases. SPTLC2, a subunit of serine palmitoyltransferase, was transcriptionally upregulated in the adipose tissues of obese mice and in differentiating adipocytes. Adipocyte-specific SPTLC2-deficient (aSPTLC2 KO) mice had markedly reduced adipose tissue mass. Fatty acids that were destined for the adipose tissue were instead shunted to liver and caused hepatosteatosis. This impaired fat distribution caused systemic insulin resistance and hyperglycemia, indicating severe lipodystrophy. Mechanistically, sphingosine 1-phosphate (S1P) was reduced in the adipose tissues of aSPTLC2 KO mice, and this inhibited adipocyte proliferation and differentiation via the downregulation of S1P receptor 1 and decreased activity of the peroxisome proliferator–activator receptor g. In addition, downregulation of SREBP (sterol regulatory element–binding protein)-1c prevented adipogenesis of aSPTLC2 KO adipocytes. Collectively, our observations suggest that the tight regulation of de novo sphingolipid biosynthesis and S1P signaling plays an important role in adipogenesis and hepatosteatosis.

Original languageEnglish
Pages (from-to)2596-2609
Number of pages14
JournalDiabetes
Volume66
Issue number10
DOIs
Publication statusPublished - 2017 Oct 1

Fingerprint

Lipodystrophy
Sphingolipids
Adipocytes
Insulin Resistance
Adipose Tissue
Adipogenesis
Metabolic Diseases
Serine C-Palmitoyltransferase
Down-Regulation
Lysosphingolipid Receptors
Obese Mice
Peroxisomes
Sterols
Hyperglycemia
Chronic Disease
Fatty Acids
Fats
Liver
Proteins

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Lee, S. Y., Lee, H. Y., Song, J. H., Kim, G. T., Jeon, S., Song, Y. J., ... Park, T. S. (2017). Adipocyte-specific deficiency of de novo sphingolipid biosynthesis leads to lipodystrophy and insulin resistance. Diabetes, 66(10), 2596-2609. https://doi.org/10.2337/db16-1232

Adipocyte-specific deficiency of de novo sphingolipid biosynthesis leads to lipodystrophy and insulin resistance. / Lee, Su Yeon; Lee, Hui Young; Song, Jae Hwi; Kim, Goon Tae; Jeon, Suwon; Song, Yoo Jeong; Lee, Jae Sung; Hur, Jang Ho; Oh, Hyun Hee; Park, Shi Young; Shim, Soon Mi; Yoo, Hyun Joo; Lee, Byung Cheon; Jiang, Xian Cheng; Choi, Cheol Soo; Park, Tae Sik.

In: Diabetes, Vol. 66, No. 10, 01.10.2017, p. 2596-2609.

Research output: Contribution to journalArticle

Lee, SY, Lee, HY, Song, JH, Kim, GT, Jeon, S, Song, YJ, Lee, JS, Hur, JH, Oh, HH, Park, SY, Shim, SM, Yoo, HJ, Lee, BC, Jiang, XC, Choi, CS & Park, TS 2017, 'Adipocyte-specific deficiency of de novo sphingolipid biosynthesis leads to lipodystrophy and insulin resistance', Diabetes, vol. 66, no. 10, pp. 2596-2609. https://doi.org/10.2337/db16-1232
Lee, Su Yeon ; Lee, Hui Young ; Song, Jae Hwi ; Kim, Goon Tae ; Jeon, Suwon ; Song, Yoo Jeong ; Lee, Jae Sung ; Hur, Jang Ho ; Oh, Hyun Hee ; Park, Shi Young ; Shim, Soon Mi ; Yoo, Hyun Joo ; Lee, Byung Cheon ; Jiang, Xian Cheng ; Choi, Cheol Soo ; Park, Tae Sik. / Adipocyte-specific deficiency of de novo sphingolipid biosynthesis leads to lipodystrophy and insulin resistance. In: Diabetes. 2017 ; Vol. 66, No. 10. pp. 2596-2609.
@article{0a1684211e434c05b7838ae707cadbd5,
title = "Adipocyte-specific deficiency of de novo sphingolipid biosynthesis leads to lipodystrophy and insulin resistance",
abstract = "Sphingolipids have been implicated in the etiology of chronic metabolic diseases. Here, we investigated whether sphingolipid biosynthesis is associated with the development of adipose tissues and metabolic diseases. SPTLC2, a subunit of serine palmitoyltransferase, was transcriptionally upregulated in the adipose tissues of obese mice and in differentiating adipocytes. Adipocyte-specific SPTLC2-deficient (aSPTLC2 KO) mice had markedly reduced adipose tissue mass. Fatty acids that were destined for the adipose tissue were instead shunted to liver and caused hepatosteatosis. This impaired fat distribution caused systemic insulin resistance and hyperglycemia, indicating severe lipodystrophy. Mechanistically, sphingosine 1-phosphate (S1P) was reduced in the adipose tissues of aSPTLC2 KO mice, and this inhibited adipocyte proliferation and differentiation via the downregulation of S1P receptor 1 and decreased activity of the peroxisome proliferator–activator receptor g. In addition, downregulation of SREBP (sterol regulatory element–binding protein)-1c prevented adipogenesis of aSPTLC2 KO adipocytes. Collectively, our observations suggest that the tight regulation of de novo sphingolipid biosynthesis and S1P signaling plays an important role in adipogenesis and hepatosteatosis.",
author = "Lee, {Su Yeon} and Lee, {Hui Young} and Song, {Jae Hwi} and Kim, {Goon Tae} and Suwon Jeon and Song, {Yoo Jeong} and Lee, {Jae Sung} and Hur, {Jang Ho} and Oh, {Hyun Hee} and Park, {Shi Young} and Shim, {Soon Mi} and Yoo, {Hyun Joo} and Lee, {Byung Cheon} and Jiang, {Xian Cheng} and Choi, {Cheol Soo} and Park, {Tae Sik}",
year = "2017",
month = "10",
day = "1",
doi = "10.2337/db16-1232",
language = "English",
volume = "66",
pages = "2596--2609",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "10",

}

TY - JOUR

T1 - Adipocyte-specific deficiency of de novo sphingolipid biosynthesis leads to lipodystrophy and insulin resistance

AU - Lee, Su Yeon

AU - Lee, Hui Young

AU - Song, Jae Hwi

AU - Kim, Goon Tae

AU - Jeon, Suwon

AU - Song, Yoo Jeong

AU - Lee, Jae Sung

AU - Hur, Jang Ho

AU - Oh, Hyun Hee

AU - Park, Shi Young

AU - Shim, Soon Mi

AU - Yoo, Hyun Joo

AU - Lee, Byung Cheon

AU - Jiang, Xian Cheng

AU - Choi, Cheol Soo

AU - Park, Tae Sik

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Sphingolipids have been implicated in the etiology of chronic metabolic diseases. Here, we investigated whether sphingolipid biosynthesis is associated with the development of adipose tissues and metabolic diseases. SPTLC2, a subunit of serine palmitoyltransferase, was transcriptionally upregulated in the adipose tissues of obese mice and in differentiating adipocytes. Adipocyte-specific SPTLC2-deficient (aSPTLC2 KO) mice had markedly reduced adipose tissue mass. Fatty acids that were destined for the adipose tissue were instead shunted to liver and caused hepatosteatosis. This impaired fat distribution caused systemic insulin resistance and hyperglycemia, indicating severe lipodystrophy. Mechanistically, sphingosine 1-phosphate (S1P) was reduced in the adipose tissues of aSPTLC2 KO mice, and this inhibited adipocyte proliferation and differentiation via the downregulation of S1P receptor 1 and decreased activity of the peroxisome proliferator–activator receptor g. In addition, downregulation of SREBP (sterol regulatory element–binding protein)-1c prevented adipogenesis of aSPTLC2 KO adipocytes. Collectively, our observations suggest that the tight regulation of de novo sphingolipid biosynthesis and S1P signaling plays an important role in adipogenesis and hepatosteatosis.

AB - Sphingolipids have been implicated in the etiology of chronic metabolic diseases. Here, we investigated whether sphingolipid biosynthesis is associated with the development of adipose tissues and metabolic diseases. SPTLC2, a subunit of serine palmitoyltransferase, was transcriptionally upregulated in the adipose tissues of obese mice and in differentiating adipocytes. Adipocyte-specific SPTLC2-deficient (aSPTLC2 KO) mice had markedly reduced adipose tissue mass. Fatty acids that were destined for the adipose tissue were instead shunted to liver and caused hepatosteatosis. This impaired fat distribution caused systemic insulin resistance and hyperglycemia, indicating severe lipodystrophy. Mechanistically, sphingosine 1-phosphate (S1P) was reduced in the adipose tissues of aSPTLC2 KO mice, and this inhibited adipocyte proliferation and differentiation via the downregulation of S1P receptor 1 and decreased activity of the peroxisome proliferator–activator receptor g. In addition, downregulation of SREBP (sterol regulatory element–binding protein)-1c prevented adipogenesis of aSPTLC2 KO adipocytes. Collectively, our observations suggest that the tight regulation of de novo sphingolipid biosynthesis and S1P signaling plays an important role in adipogenesis and hepatosteatosis.

UR - http://www.scopus.com/inward/record.url?scp=85029798342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029798342&partnerID=8YFLogxK

U2 - 10.2337/db16-1232

DO - 10.2337/db16-1232

M3 - Article

C2 - 28698261

AN - SCOPUS:85029798342

VL - 66

SP - 2596

EP - 2609

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 10

ER -